New considerations in the medical management of early Parkinson's disease: impact of recent clinical trials on treatment strategy. [electronic resource]
- Parkinsonism & related disorders Dec 2009
- S17-21 p. digital
Publication Type: Journal Article; Review
1873-5126
10.1016/S1353-8020(09)70772-2 doi
Antiparkinson Agents--therapeutic use Disruptive, Impulse Control, and Conduct Disorders--chemically induced Dopamine Agents--adverse effects Humans Monoamine Oxidase Inhibitors--adverse effects Parkinson Disease--complications